07/28/2026
New biotech companies are entering the weight-loss drug space, bringing fresh approaches to one of the fastest-growing areas in healthcare innovation. Here's more.
A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has taken the world by storm.